Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Verrica Pharmaceuticals Inc 44 West Gay Street Suite 400 WEST CHESTER PA 19380 USA

www.verrica.com P: 484-453-3300

Description:

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.

Key Statistics

Overview:

Market Capitalization, $K 363,115
Enterprise Value, $K 336,435
Shares Outstanding, K 42,420
Annual Sales, $ 5,120 K
Annual Net Income, $ -67,000 K
Last Quarter Sales, $ 3,830 K
Last Quarter Net Income, $ -20,330 K
EBIT, $ -74,740 K
EBITDA, $ -73,900 K
60-Month Beta 1.82
% of Insider Shareholders 42.60%
% of Institutional Shareholders 42.45%
Float, K 24,349
% Float 57.40%
Short Volume Ratio 0.50

Growth:

1-Year Return 46.43%
3-Year Return -13.82%
5-Year Return 3.69%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 19.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 05/13/24
Next Earnings Date N/A
Earnings Per Share ttm -1.48
EPS Growth vs. Prev Qtr 8.33%
EPS Growth vs. Prev Year -193.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VRCA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -229.26%
Return-on-Assets % -88.77%
Profit Margin % -1,308.59%
Debt/Equity 28.38
Price/Sales 69.13
Price/Cash Flow N/A
Price/Book 240.79
Book Value/Share 0.04
Interest Coverage -15.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar